Emapalumab in the Treatment of Adult Patients with Malignancy-Associated Hemophagocytic Lymphohistiocytosis (mHLH)

• ACCP •
• 18 October, 2025 •
• •

Hemophagocytic Lymphohistiocytosis (HLH): A Survey Study on Pharmacists’ Practice Patterns and Perceptions

Ashley Teusink-Cross, Christopher McPherson, Astrela Moore, Ingrid Pan, Amod Athavale, Amal Gulaid, Bhagyashree Oak, Brittany Smith, Abiola Oladapo, Matthew Wojdyla, Lynes Torres Cartularo

Available materials

• ASH •
• 9 December, 2024 •
• •

Patients (pts) with Optimized Hemophagocytic Lymphohistiocytosis (HLH) Inflammatory (OHI) Index-Confirmed Diagnosis of Malignancy-Associated HLH (mHLH) and Emapalumab Treatment

Naval Daver, Andrew Danquah, Didier Halimi, Jérôme Wojcik, Emmanuel Monnet

• ASH •
• 8 December, 2024 •
• •

Transplant Related Outcomes in Patients with Hemophagocytic Lymphohistiocytosis Treated with Emapalumab as a Bridge to Hematopoietic Stem Cell Transplantation: The Real-HLH Study

Carl E. Allen, Shanmuganathan Chandrakasan, Michael B. Jordan, Jennifer W. Leiding, Michael Marrone, Abiola Oladapo, Priti Pednekar, Kelly J. Walkovich, John Yee